To our knowledge, this review article presents a thorough summary of the latest research on the mechanism of action of SGLT-2 inhibitors, their ketogenesis, and their potential synergy with the ketogenic diet for managing diabetes. The gene discussed is SLC5A2; the disease is diabetes mellitus.